Hornet Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $5M

  • Investors
  • 3

Hornet Therapeutics General Information

Description

Developer of a biotech company designed to develop treatments to address Epstein-Barr virus-driven pathologies. The company has established single-gene-level precision engineering of immune cell metabolism to induce or abolish specific cellular states, enabling healthcare professionals to offer treatment options for preventing EBV-implicated diseases, including post-transplantation lymphoproliferative disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 48 Warwick Street
  • London W1B 5AW
  • England, United Kingdom
+44 020
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 48 Warwick Street
  • London W1B 5AW
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hornet Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 23-May-2024 $5M Completed Clinical Trials - General
3. Early Stage VC 09-Mar-2020 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Spin-Off Completed Startup
To view Hornet Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Hornet Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hornet Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
4BIO Capital Venture Capital Minority
Innovation Office (Accelerator/Incubator) Accelerator/Incubator
Unitectra Corporation
To view Hornet Therapeutics’s complete investors history, request access »

Hornet Therapeutics FAQs

  • When was Hornet Therapeutics founded?

    Hornet Therapeutics was founded in 2019.

  • Where is Hornet Therapeutics headquartered?

    Hornet Therapeutics is headquartered in London, United Kingdom.

  • What is the size of Hornet Therapeutics?

    Hornet Therapeutics has 3 total employees.

  • What industry is Hornet Therapeutics in?

    Hornet Therapeutics’s primary industry is Drug Discovery.

  • Is Hornet Therapeutics a private or public company?

    Hornet Therapeutics is a Private company.

  • What is Hornet Therapeutics’s current revenue?

    The current revenue for Hornet Therapeutics is .

  • How much funding has Hornet Therapeutics raised over time?

    Hornet Therapeutics has raised $8.09M.

  • Who are Hornet Therapeutics’s investors?

    4BIO Capital, Innovation Office (Accelerator/Incubator), and Unitectra have invested in Hornet Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process